お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙:疼痛管理薬の世界市場:業界動向、市場シェア・規模・成長率・機会および予測(2021年~2026年)
市場調査レポート
商品コード
999842

疼痛管理薬の世界市場:業界動向、市場シェア・規模・成長率・機会および予測(2021年~2026年)

Pain Management Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

出版日: | 発行: IMARC Services Private Limited | ページ情報: 英文 108 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.22円
疼痛管理薬の世界市場:業界動向、市場シェア・規模・成長率・機会および予測(2021年~2026年)
出版日: 2021年04月12日
発行: IMARC Services Private Limited
ページ情報: 英文 108 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の疼痛管理薬の市場規模は、2020年に740億米ドルに達しました。疼痛管理薬は、疼痛受容体に薬理作用があり、不快感の原因となる症状に作用します。これらの薬は、さまざまな生理学的機能を介して作用することにより、変形性関節症、慢性関節炎、糖尿病性ニューロパチー、多発性硬化症、癌などのさまざまな健康問題によって引き起こされる苦痛を和らげます。近年、医学の進歩により、疼痛管理を改善する新しい組み合わせと新しい薬物送達技術が導入されています。

世界市場を牽引する主要な要因の1つは、世界中で高齢者人口が増加していることです。 2018年の60歳以上の人口は約9億9,100万人でした。この人口は2024年までに11億8,000万人に達すると予測されています。慢性疼痛の有病率は高齢者で著しく高く、疼痛管理薬の需要は世界中で拡大しています。さらに、入院症例数の増加と効果的な神経因性疼痛管理薬の需要と供給の大きなギャップにより、革新的で先進的治療法や医薬品が登場しています。さらに、大手製薬企業は、より安全で、より効果的で、経済的に実行可能で、管理が容易な鎮痛剤を開発するための研究開発(R&D)活動に多額の投資を行っています。医療費の増加、研究開発の改善、消費者の意識の高まり、ヘルスケアサービスの改善に対する政府の大きな支援など、その他の要因が市場成長を後押ししています。世界の疼痛管理薬市場は、2021年から2026年の予測期間の間に緩やかな成長を示すと予想されています。

当レポートは、世界の疼痛管理薬市場について調査しており、業界動向、市場予測、薬物クラス・適応症・流通チャネル・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 序文

第2章 範囲と調査方法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界の疼痛管理薬市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 薬物クラス別の市場セグメンテーション
  • 適応症別の市場セグメンテーション
  • 流通チャネル別の市場セグメンテーション
  • 地域別の市場セグメンテーション

第6章 薬物クラス別の市場セグメンテーション

  • NSAID
  • 麻酔薬
  • 抗けいれん薬
  • 抗片頭痛剤
  • 抗うつ薬
  • オピオイド
  • その他

第7章 適応症別市場セグメンテーション

  • 筋骨格痛
  • 外科的および外傷性の痛み
  • 癌性疼痛
  • 神経因性疼痛
  • 片頭痛
  • 分娩痛
  • 線維筋痛
  • 灼熱痛
  • 歯科/顔面痛
  • 小児の痛み
  • その他

第8章 流通チャネル別の市場セグメンテーション

  • 病院薬局
  • 小売薬局
  • オンライン薬局

第9章 地域別の市場セグメンテーション

  • 北米
  • 欧州
  • アジア太平洋地域
  • 中東・アフリカ
  • ラテンアメリカ

第10章 SWOT分析

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

第13章 価格分析

  • 価格指標
  • 価格構造
  • マージン分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業 のプロファイル
    • Abbott Laboratories, Inc.
    • Pfizer, Inc.
    • Eli Lilly & Company
    • Endo International plc
    • F. Hoffmann-La Roche AG
    • Bausch Health Companies, Inc.
    • Merck & Co. Inc.
    • Allergen Inc.
    • Novartis International AG
    • Johnson & Johnson Private Limited
    • GlaxoSmithKline Plc
    • Purdue Pharma L.P
図表

List of Figures

  • Figure 1: Global: Pain Management Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Pain Management Drugs Market: Sales Value (in Billion US$), 2015 - 2020
  • Figure 3: Global: Pain Management Drugs Market: Breakup by Drug Class (in %), 2020
  • Figure 4: Global: Pain Management Drugs Market: Breakup by Indication (in %), 2020
  • Figure 5: Global: Pain Management Drugs Market: Breakup by Distribution Channel (in %), 2020
  • Figure 6: Global: Pain Management Drugs Market: Breakup by Region (in %), 2020
  • Figure 7: Global: Pain Management Drugs Market Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 8: Global: Pain Management Drugs Industry: SWOT Analysis
  • Figure 9: Global: Pain Management Drugs Industry: Value Chain Analysis
  • Figure 10: Global: Pain Management Drugs Industry: Porter's Five Forces Analysis
  • Figure 11: Global: Pain Management Drugs (NSAIDs) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 12: Global: Pain Management Drugs (NSAIDs) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 13: Global: Pain Management Drugs (Anesthetics) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 14: Global: Pain Management Drugs (Anesthetics) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 15: Global: Pain Management Drugs (Anticonvulsants) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 16: Global: Pain Management Drugs (Anticonvulsants) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 17: Global: Pain Management Drugs (Antimigraine Agents) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 18: Global: Pain Management Drugs (Antimigraine Agents) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 19: Global: Pain Management Drugs (Antidepressants) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 20: Global: Pain Management Drugs (Antidepressants) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 21: Global: Pain Management Drugs (Opioids) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 22: Global: Pain Management Drugs (Opioids) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 23: Global: Pain Management Drugs (Other Drug Classes) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 24: Global: Pain Management Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 25: Global: Pain Management Drugs (Musculoskeletal Pain) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 26: Global: Pain Management Drugs (Musculoskeletal Pain) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 27: Global: Pain Management Drugs (Surgical and Trauma Pain) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 28: Global: Pain Management Drugs (Surgical and Trauma Pain) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 29: Global: Pain Management Drugs (Cancer Pain) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 30: Global: Pain Management Drugs (Cancer Pain) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 31: Global: Pain Management Drugs (Neuropathic Pain) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 32: Global: Pain Management Drugs (Neuropathic Pain) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 33: Global: Pain Management Drugs (Migraine Pain) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 34: Global: Pain Management Drugs (Migraine Pain) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 35: Global: Pain Management Drugs (Obstetrical Pain) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 36: Global: Pain Management Drugs (Obstetrical Pain) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 37: Global: Pain Management Drugs (Fibromyalgia Pain) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 38: Global: Pain Management Drugs (Fibromyalgia Pain) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 39: Global: Pain Management Drugs (Burn Pain) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 40: Global: Pain Management Drugs (Burn Pain) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 41: Global: Pain Management Drugs (Dental/Facial Pain) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 42: Global: Pain Management Drugs (Dental/Facial Pain) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 43: Global: Pain Management Drugs (Pediatric Pain) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 44: Global: Pain Management Drugs (Pediatric Pain) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 45: Global: Pain Management Drugs (Other Indications) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 46: Global: Pain Management Drugs (Other Indications) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 47: Global: Pain Management Drugs Market: Sales through Hospital Pharmacies (in Million US$), 2015 & 2020
  • Figure 48: Global: Pain Management Drugs Market Forecast: Sales through Hospital Pharmacies (in Million US$), 2021-2026
  • Figure 49: Global: Pain Management Drugs Market: Sales through Retail Pharmacies (in Million US$), 2015 & 2020
  • Figure 50: Global: Pain Management Drugs Market Forecast: Sales through Retail Pharmacies (in Million US$), 2021-2026
  • Figure 51: Global: Pain Management Drugs Market: Sales through Online Pharmacies (in Million US$), 2015 & 2020
  • Figure 52: Global: Pain Management Drugs Market Forecast: Sales through Online Pharmacies (in Million US$), 2021-2026
  • Figure 53: North America: Pain Management Drugs Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 54: North America: Pain Management Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 55: Europe: Pain Management Drugs Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 56: Europe: Pain Management Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 57: Asia Pacific: Pain Management Drugs Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 58: Asia Pacific: Pain Management Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 59: Middle East and Africa: Pain Management Drugs Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 60: Middle East and Africa: Pain Management Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 61: Latin America: Pain Management Drugs Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 62: Latin America: Pain Management Drugs Market Forecast: Sales Value (in Million US$), 2021-2026

List of Tables

  • Table 1: Global: Pain Management Drugs Market: Key Industry Highlights, 2020 and 2026
  • Table 2: Global: Pain Management Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2021-2026
  • Table 3: Global: Pain Management Drugs Market Forecast: Breakup by Indication (in Million US$), 2021-2026
  • Table 4: Global: Pain Management Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2021-2026
  • Table 5: Global: Pain Management Drugs Market Forecast: Breakup by Region (in Million US$), 2021-2026
  • Table 6: Global: Pain Management Drugs Market Structure
  • Table 7: Global: Pain Management Drugs Market: Key Players
目次
Product Code: SR1020B228_Report

The global pain management drugs market reached a value of US$ 74 Billion in 2020. Pain management drugs perform pharmacological actions on pain receptors and work against discomfort-causing symptoms. These medications provide relief from the distressing feeling caused due to various health issues, such as osteoarthritis, chronic arthritis, diabetic neuropathy, multiple sclerosis and cancer, by acting through different physiological functions. In recent years, medical advancements have led to the introduction of novel combinations and newer drug delivery techniques that provide improved pain management.

One of the key factors driving the global market is the rising geriatric population across the globe. In 2018, the population of people aged 60 years and above was around 991 million. This population is projected to reach 1.18 billion by 2024. With the prevalence of chronic pain being significantly higher in older adults, the demand for pain management drugs is escalating across the globe. Furthermore, a rise in the number of hospitalization cases and a huge demand-supply gap for effective neuropathic pain management drugs have led to the emergence of innovative and advanced therapies and medicines. Moreover, the leading pharmaceutical companies are investing heavily in research and development (R&D) activities to develop analgesics or painkillers that are safer, more effective, economically viable and easier to administer. Other factors, including rising healthcare expenditure, improving R&D, increasing consumer awareness, and significant government support for improving healthcare services, are driving the growth of the market. Looking forward, IMARC Group expects the global pain management drugs market to exhibit moderate growth during the forecast period (2021-2026).

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global pain management drugs market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region,drug class, indication and distribution channel.

Report Coverage:

  • Historical, Current and Future Market Trends

Market Breakup by Drug Class:

  • NSAIDs
  • Anesthetics
  • Anticonvulsants
  • Antimigraine Agents
  • Antidepressants
  • Opioids
  • Others

Market Breakup by Indication:

  • Musculoskeletal Pain
  • Surgical and Trauma Pain
  • Cancer Pain
  • Neuropathic Pain
  • Migraine Pain
  • Obstetrical Pain
  • Fibromyalgia Pain
  • Burn Pain
  • Dental/Facial Pain
  • Pediatric Pain
  • Others

Market Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Market Breakup by Region:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Competitive Landscape:

  • The report has also analysed the competitive landscape of the market with some of the pain management drugs companies being Abbott Laboratories, Inc., Pfizer, Inc., Eli Lilly & Company, Endo International plc, F. Hoffmann-La Roche AG, Bausch Health Companies, Inc., Merck & Co. Inc., Allergen Inc., Novartis International AG, Johnson & Johnson Private Limited, GlaxoSmithKline Plc and Purdue Pharma L.P, etc.

Key Questions Answered in This Report:

  • 1. What was the global pain management drugs market size in 2020?
  • 2. What are the key global pain management drugs market drivers?
  • 3. Who are the leading pain management drug manufacturers?
  • 4. What is the pain management drugs market breakup by distribution channel?
  • 5. How will the global pain management drugs market perform over the next five years (2021-2026)?
  • 6. What is the leading drug class in the global pain management drugs market?
  • 7. What is the major indication in the global pain management drugs market?
  • 8. What are the major trends in the global pain management drugs market?
  • 9. What is the impact of COVID-19 on the global pain management drugs market?
  • 10. What are the major regions in the global pain management drugs market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Pain Management Drugs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Drug Class
  • 5.5 Market Breakup by Indication
  • 5.6 Market Breakup by Distribution Channel
  • 5.7 Market Breakup by Region
  • 5.8 Market Forecast

6 Market Breakup by Drug Class

  • 6.1 NSAIDs
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Anesthetics
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Anticonvulsants
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Antimigraine Agents
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Antidepressants
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Opioids
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Others
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast

7 Market Breakup by Indication

  • 7.1 Musculoskeletal Pain
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Surgical and Trauma Pain
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Cancer Pain
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Neuropathic Pain
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Migraine Pain
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Obstetrical Pain
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Fibromyalgia Pain
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast
  • 7.8 Burn Pain
    • 7.8.1 Market Trends
    • 7.8.2 Market Forecast
  • 7.9 Dental/Facial Pain
    • 7.9.1 Market Trends
    • 7.9.2 Market Forecast
  • 7.10 Pediatric Pain
    • 7.10.1 Market Trends
    • 7.10.2 Market Forecast
  • 7.11 Others
    • 7.11.1 Market Trends
    • 7.11.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Pharmacies
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Europe
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Asia Pacific
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Middle East and Africa
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Latin America
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

  • 13.1 Price Indicators
  • 13.2 Price Structure
  • 13.3 Margin Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories, Inc.
    • 14.3.2 Pfizer, Inc.
    • 14.3.3 Eli Lilly & Company
    • 14.3.4 Endo International plc
    • 14.3.5 F. Hoffmann-La Roche AG
    • 14.3.6 Bausch Health Companies, Inc.
    • 14.3.7 Merck & Co. Inc.
    • 14.3.8 Allergen Inc.
    • 14.3.9 Novartis International AG
    • 14.3.10 Johnson & Johnson Private Limited
    • 14.3.11 GlaxoSmithKline Plc
    • 14.3.12 Purdue Pharma L.P
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.